Pluri (PLUR) Operating Expenses (2010 - 2025)
Pluri (PLUR) reported Operating Expenses of $2.7 million for Q4 2025, up 622.4% year-over-year from $368080.2 in Q4 2024, and up 6.11% quarter-over-quarter from $2.5 million in Q3 2025.
Pluri (PLUR) Operating Expenses (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Operating Expenses data on file, last reported at $2.7 million in Q4 2025.
- Operating Expenses for Q4 2025 came in at $2.7 million, up 622.4% year-over-year; the trailing twelve-month figure through Dec 2025 was $17.9 million (up 27.55% YoY), and the FY2025 annual result was $9.8 million, up 30.64% from the prior year.
- Operating Expenses climbed to $2.7 million in Q4 2025 per PLUR's latest filing, from $2.5 million in the prior quarter.
- Over five years, Operating Expenses peaked at $14.6 million in Q2 2021 and troughed at -$15.5 million in Q2 2022.
- A 5-year average of $5.8 million and a median of $6.0 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses tumbled 205.8% in 2022, then surged 622.4% in 2025.
- A 5-year view of Operating Expenses shows it stood at $10.8 million in 2021, then sank by 38.3% to $6.7 million in 2022, then fell by 18.99% to $5.4 million in 2023, then sank by 109.41% to -$509000.0 in 2024, then surged by 622.4% to $2.7 million in 2025.
- Business Quant data shows PLUR's Operating Expenses at $2.7 million in Q4 2025, $2.5 million in Q3 2025, and $7.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 15.76 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -67.40 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 2.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.66 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | 7.04 Mn |
| Mar 31, 2025 | 5.73 Mn |
| Dec 31, 2024 | -509,000.00 |
| Sep 30, 2024 | 2.83 Mn |
| Jun 30, 2024 | 6.12 Mn |
| Mar 31, 2024 | 5.62 Mn |
| Dec 31, 2023 | 5.41 Mn |
| Sep 30, 2023 | 5.80 Mn |
| Jun 30, 2023 | 5.46 Mn |
| Mar 31, 2023 | 7.66 Mn |
| Dec 31, 2022 | 6.68 Mn |
| Sep 30, 2022 | 7.01 Mn |
| Jun 30, 2022 | -15.46 Mn |
| Mar 31, 2022 | 10.83 Mn |
| Dec 31, 2021 | 10.83 Mn |
| Sep 30, 2021 | 11.44 Mn |
| Jun 30, 2021 | 14.61 Mn |
| Mar 31, 2021 | 14.23 Mn |